These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 31042721)

  • 1. The association and prognostic impact of enhancer of zeste homologue 2 expression and epithelial-mesenchymal transition in resected lung adenocarcinoma.
    Matsubara T; Toyokawa G; Takada K; Kinoshita F; Kozuma Y; Akamine T; Shimokawa M; Haro A; Osoegawa A; Tagawa T; Mori M
    PLoS One; 2019; 14(5):e0215103. PubMed ID: 31042721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Prognostic Significance of the Epithelial-Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score-Matched Analysis.
    Matsubara T; Tagawa T; Takada K; Toyokawa G; Shimokawa M; Kozuma Y; Akamine T; Haro A; Osoegawa A; Mori M
    Clin Lung Cancer; 2019 Jul; 20(4):e504-e513. PubMed ID: 31103348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of epithelial-mesenchymal transition-related molecules in lung adenocarcinoma.
    Zhang Y; Wang LF; Gao JH; Li L; Jiang P; Lv X; Yu LX; Yang J; Li RT; Liu BR
    Curr Oncol; 2019 Apr; 26(2):e121-e127. PubMed ID: 31043817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of IFITM1 expression and correlation with microvessel density and epithelial-mesenchymal transition signature in lung adenocarcinoma.
    Koh YW; Han JH; Jeong D; Kim CJ
    Pathol Res Pract; 2019 Jul; 215(7):152444. PubMed ID: 31079850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
    Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
    Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
    Li J; Liu Y; Xue J; Xu M; Zhang J; Liu J; Wang W
    Pathol Oncol Res; 2019 Jan; 25(1):115-121. PubMed ID: 28986741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.
    Chang JW; Gwak SY; Shim GA; Liu L; Lim YC; Kim JM; Jung MG; Koo BS
    Oral Oncol; 2016 Jan; 52():66-74. PubMed ID: 26604082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
    Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
    Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
    Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
    World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated vimentin and upregulated E-cadherin in T1 stage non-small-cell lung cancer: does it suggest a mesenchymal-epithelial transition?
    Luo T; Wang L; Wu P; Gong W; Chen W; Zhao H; Zheng Z
    Neoplasma; 2017; 64(5):693-699. PubMed ID: 28592120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma.
    Sowa T; Menju T; Sonobe M; Nakanishi T; Shikuma K; Imamura N; Motoyama H; Hijiya K; Aoyama A; Chen F; Sato T; Kobayashi M; Yoshizawa A; Haga H; Sozu T; Date H
    Cancer Med; 2015 Dec; 4(12):1853-62. PubMed ID: 26471868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-mesenchymal Transition (EMT) is Correlated with Patient's Prognosis of Lung Squamous Cell Carcinoma.
    Aruga N; Kijima H; Masuda R; Onozawa H; Yoshizawa T; Tanaka M; Inokuchi S; Iwazaki M
    Tokai J Exp Clin Med; 2018 Apr; 43(1):5-13. PubMed ID: 29637533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma.
    Shi Y; Wu H; Zhang M; Ding L; Meng F; Fan X
    Diagn Pathol; 2013 May; 8():89. PubMed ID: 23706092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Positive Correlation Between the EZH2 and PD-L1 Expression in Resected Lung Adenocarcinomas.
    Toyokawa G; Takada K; Tagawa T; Hamamoto R; Yamada Y; Shimokawa M; Oda Y; Maehara Y
    Ann Thorac Surg; 2019 Feb; 107(2):393-400. PubMed ID: 30343006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of PD-L1, cancer stem cell and epithelial-mesenchymal transition phenotype in non-small cell lung cancer.
    Koh YW; Han JH; Haam S
    Pathology; 2021 Feb; 53(2):239-246. PubMed ID: 33036771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma.
    Zhang Y; Sun L; Gao X; Guo A; Diao Y; Zhao Y
    BMC Cancer; 2019 Jul; 19(1):670. PubMed ID: 31286874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis.
    Zhang Q; Dong P; Liu X; Sakuragi N; Guo SW
    Sci Rep; 2017 Jul; 7(1):6804. PubMed ID: 28754964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Twist-1, E-cadherin and EZH2 in Prostate Cancer: An Immunohistochemical Study.
    Abdelrahman AE; Arafa SA; Ahmed RA
    Turk Patoloji Derg; 2017; 1(1):198-210. PubMed ID: 28832071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.